cetpinhibition.org

Mechanisms

Bulky hydrophobic residues Leu475, Phe471, Leu468, Phe461 and Phe454 on one face of a C-terminal helix drive CETP's cholesteryl-ester transfer activity, distinct from the antibody-binding face (J Biol Chem 1993)

Original title: Point mutagenesis of carboxyl-terminal amino acids of cholesteryl ester transfer protein. Opposite faces of an amphipathic helix important for cholesteryl ester transfer or for binding neutralizing antibody

J Biol Chem · · 8

Wang S, Wang X, Deng L, Rassart E, Milne RW, Tall AR

A carboxyl-terminal CETP sequence forms the epitope of the neutralizing monoclonal antibody TP2 and is required for neutral lipid transfer activity. To dissect individual residues' roles, the authors made single amino acid substitution mutants between Pro446 and Ser476 and expressed them in mammalian cells. TP2 binding was abolished by mutations of polar or charged residues occurring periodically between His466 and Leu475 and at Asp460, yet these mutants retained well-preserved cholesteryl ester (CE) transfer activity. In contrast, mutating bulky hydrophobic residues in this region (particularly Leu475, Phe471, Leu468, Phe461 and Phe454) markedly decreased CE transfer activity while preserving normal TP2 binding. This paradox fits a model placing antibody-binding and activity-determining residues on opposite faces of an amphipathic helix between residues 465-476, confirmed by alanine substitution of contiguous nonpolar residue pairs, producing low-activity mutants matching deletions of this region.

PubMed

Original abstract

The cholesteryl ester transfer protein (CETP) mediates the transfer of neutral lipids between the plasma lipoproteins. A carboxyl-terminal sequence of CETP was recently shown to form the epitope of a neutralizing monoclonal antibody (TP2) and to be necessary for neutral lipid transfer activity. To determine the role of specific amino acids in the epitope and/or in lipid transfer activity, we made single amino acid substitution mutants between Pro446 and Ser476 by in vitro mutagenesis and expressed the mutants in mammalian cells. The binding of TP2 to CETP was abolished by mutations primarily of polar or charged amino acids that occurred periodically within the sequence between His466 and Leu475 and at amino acid Asp460; however, these mutants had well preserved cholesteryl ester (CE) transfer activity. By contrast, mutants of bulky hydrophobic amino acids in this region (particularly Leu475, Phe471, Leu468, Phe461, and Phe454) showed markedly decreased CE transfer specific activity, but essentially normal binding of TP2. The paradoxical effects on antibody binding and activity could be explained if amino acids determining monoclonal antibody binding and activity are disposed on opposite faces of an amphipathic helix between amino acids 465 and 476. This model was tested by substituting alanine residues for pairs of nonpolar amino acids which would be contiguous on a helix, resulting in low activity mutants equivalent to those produced by deletion of this region. We conclude that the hydrophobic face of a carboxyl-terminal helix of CETP is directly involved in the mechanism of CE transfer, and that TP2 inhibits activity by local sterical hindrance. The general hydrophobic character of this region, imparted by the bulky hydrophobic amino acids Leu and Phe, is important for normal CE transfer.

mechanisms

Summary written by cetpinhibition.org from the published abstract; figures as published. Page updated 19 August 2026. Methods.